The natural course of cystic pancreatic neuroendocrine tumours in MEN1

Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered...

Full description

Saved in:
Bibliographic Details
Published inEndocrine oncology Vol. 5; no. 1; p. e240050
Main Authors van Vliembergen, Eline N M, Pieterman, Carolina R C, van de Ven, Annenienke C, Braat, Arthur J A T, Valk, Gerlof D, de Laat, Joanne M
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 01.01.2025
Bioscientifica
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ 68 Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ 68 Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.
AbstractList Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ 68 Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ 68 Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.
Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [68Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [68Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [68Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [68Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.
Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.
Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ 68 Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ 68 Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.
Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [68Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [68Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.
Author de Laat, Joanne M
Pieterman, Carolina R C
Braat, Arthur J A T
Valk, Gerlof D
van de Ven, Annenienke C
van Vliembergen, Eline N M
AuthorAffiliation 3 Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht , Utrecht , The Netherlands
2 Department of Endocrinology, Radboud University Medical Centre , Nijmegen , The Netherlands
1 Department of Endocrine Oncology, University Medical Centre Utrecht , Utrecht , The Netherlands
AuthorAffiliation_xml – name: 2 Department of Endocrinology, Radboud University Medical Centre , Nijmegen , The Netherlands
– name: 1 Department of Endocrine Oncology, University Medical Centre Utrecht , Utrecht , The Netherlands
– name: 3 Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht , Utrecht , The Netherlands
Author_xml – sequence: 1
  givenname: Eline N M
  orcidid: 0009-0008-9872-5937
  surname: van Vliembergen
  fullname: van Vliembergen, Eline N M
  organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands, Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands
– sequence: 2
  givenname: Carolina R C
  surname: Pieterman
  fullname: Pieterman, Carolina R C
  organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 3
  givenname: Annenienke C
  surname: van de Ven
  fullname: van de Ven, Annenienke C
  organization: Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands
– sequence: 4
  givenname: Arthur J A T
  surname: Braat
  fullname: Braat, Arthur J A T
  organization: Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 5
  givenname: Gerlof D
  surname: Valk
  fullname: Valk, Gerlof D
  organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 6
  givenname: Joanne M
  surname: de Laat
  fullname: de Laat, Joanne M
  organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands, Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39949334$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1P3DAQhi1EBRS48ANQjggprb8_ThVaLS0S7V7o2XLsMQRl7a2dIPHvyXYBwckjz6NnRvN-RfspJ0DojOBvRDD8fblqKW8xFngPHVHJeMuVYfsf6kN0WusjxphqRbWUB-iQGcMNY_wIXd89QJPcOBU3ND5PpUKTY-Of69j7ZuOSL-C2ZYKpZEgh-9InaMZpvYWbPjW_l3_ICfoS3VDh9PU9Rn-vl3eLX-3t6ufN4uq29ZQb3GqqvAkiOq5pEEwFHLEBTIOUXVDeGaM0F4QrRTsmTdSsIzgEhyWJPDrMjtHNzhuye7Sb0q9debbZ9fb_Ry731pV53QGsjrOCdEAFjVxxrbnj3DFFoqS402x2_di5NlO3huAhjfMRPkk_d1L_YO_zkyVEU0Gkng0Xr4aS_01QR7vuq4dhcAnyVC0jUiopBRUzev5x2PuUtyRm4HIH-JJrLRDfEYLtNmm7XFnK7TZp9gKq4JjM
ContentType Journal Article
Copyright the author(s).
the author(s) 2025 the author(s)
Copyright_xml – notice: the author(s).
– notice: the author(s) 2025 the author(s)
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1530/EO-24-0050
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2634-4793
ExternalDocumentID oai_doaj_org_article_8fb361be252f474884a44a371f620b83
PMC11825168
39949334
10_1530_EO_24_0050
Genre Journal Article
GrantInformation_xml – fundername: ;
  grantid: 13575
GroupedDBID 53G
AAFZV
AAKMT
AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
EBS
GROUPED_DOAJ
M~E
PGMZT
RPM
TBS
NPM
7X8
5PM
ID FETCH-LOGICAL-c2490-827c9d5fa482d537d0f09e02d66bd7ca99784514772b369f83b10dda061f4fa03
IEDL.DBID DOA
ISSN 2634-4793
IngestDate Wed Aug 27 01:25:06 EDT 2025
Thu Aug 21 18:29:19 EDT 2025
Fri Jul 11 04:47:24 EDT 2025
Sun Feb 16 01:21:12 EST 2025
Wed Sep 03 16:33:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords natural course
histopathology
multiple endocrine neoplasia type 1
pancreatic neuroendocrine tumour
cystic
Language English
License the author(s).
This work is licensed under a Creative Commons Attribution 4.0 International License.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2490-827c9d5fa482d537d0f09e02d66bd7ca99784514772b369f83b10dda061f4fa03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0009-0008-9872-5937
0000-0003-3316-1540
OpenAccessLink https://doaj.org/article/8fb361be252f474884a44a371f620b83
PMID 39949334
PQID 3166766525
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_8fb361be252f474884a44a371f620b83
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11825168
proquest_miscellaneous_3166766525
pubmed_primary_39949334
crossref_primary_10_1530_EO_24_0050
PublicationCentury 2000
PublicationDate 2025-Jan
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-Jan
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bristol
PublicationTitle Endocrine oncology
PublicationTitleAlternate Endocr Oncol
PublicationYear 2025
Publisher Bioscientifica Ltd
Bioscientifica
Publisher_xml – name: Bioscientifica Ltd
– name: Bioscientifica
References Thakker RV (bib12) 2012; 97
Khoury T (bib7) 2024; 36
Bordeianou L (bib2) 2008; 206
Niederle B (bib8) 2021; 111
Virgolini I (bib16) 2016; 43
van Beek DJ (bib14) 2023; 32
de Laat JM (bib3) 2013; 98
Sakurai A (bib9) 2012; 76
van Beek DJ (bib13) 2018; 7
Takeshita K (bib11) 1994; 19
de Laat JM (bib4) 2016; 14
Goudet P (bib6) 2011; 165
Singhi AD (bib10) 2012; 36
Zhu JK (bib17) 2019; 19
Goudet P (bib5) 2010; 34
Ahrendt SA (bib1) 2002; 6
van Vliembergen ENM (bib15) 2023; 14
References_xml – volume: 7
  start-page: R260
  year: 2018
  ident: bib13
  article-title: ‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1
– volume: 76
  start-page: 533
  year: 2012
  ident: bib9
  article-title: Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database
– volume: 97
  start-page: 2990
  year: 2012
  ident: bib12
  article-title: Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
– volume: 14
  start-page: 182
  year: 2016
  ident: bib4
  article-title: MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients
– volume: 19
  start-page: 225
  year: 1994
  ident: bib11
  article-title: Cystic islet cell tumors: radiologic findings in three cases
– volume: 19
  start-page: 738
  year: 2019
  ident: bib17
  article-title: Cystic pancreatic neuroendocrine tumors: a distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis
– volume: 206
  start-page: 1154
  year: 2008
  ident: bib2
  article-title: Cystic pancreatic endocrine neoplasms: a distinct tumor type?
– volume: 98
  start-page: 4143
  year: 2013
  ident: bib3
  article-title: Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients
– volume: 34
  start-page: 249
  year: 2010
  ident: bib5
  article-title: Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients
– volume: 36
  start-page: 395
  year: 2024
  ident: bib7
  article-title: Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: systematic review and meta-analysis
– volume: 14
  year: 2023
  ident: bib15
  article-title: Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs
– volume: 165
  start-page: 97
  year: 2011
  ident: bib6
  article-title: Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines
– volume: 36
  start-page: 1666
  year: 2012
  ident: bib10
  article-title: Cystic pancreatic neuroendocrine tumors: a clinicopathologic study
– volume: 43
  start-page: 2072
  year: 2016
  ident: bib16
  article-title: Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours
– volume: 6
  start-page: 66
  year: 2002
  ident: bib1
  article-title: Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible?
– volume: 111
  start-page: 609
  year: 2021
  ident: bib8
  article-title: Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome–an international consensus statement
– volume: 32
  start-page: 343
  year: 2023
  ident: bib14
  article-title: Status of surveillance and nonsurgical therapy for small nonfunctioning pancreatic neuroendocrine tumors
SSID ssj0002872866
Score 2.2789683
Snippet Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e240050
SubjectTerms cystic
histopathology
multiple endocrine neoplasia type 1
natural course
pancreatic neuroendocrine tumour
Title The natural course of cystic pancreatic neuroendocrine tumours in MEN1
URI https://www.ncbi.nlm.nih.gov/pubmed/39949334
https://www.proquest.com/docview/3166766525
https://pubmed.ncbi.nlm.nih.gov/PMC11825168
https://doaj.org/article/8fb361be252f474884a44a371f620b83
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQB8QFFWhp-JKr9hoRf8Y5AtoVQlr2UiRuluMPFaQmVbt74N8z44TVboXEhWtiKda8seY9Z_xMyI-aSeUTqBNnYlXKoJrScTyxDAnDHFSIEFAozu70zb28fVAPa1d9YU_YYA88BO7CpFZo1kaueJI1pJt0UjpRs6R51Zrs8wk1b01MPeUto5obrUc_UiWqi8m85LJEu5ONCpSN-t9il_83Sa5VneknsjfSRXo5THOfbMXugOzMxh_ih2QKMNNszgmjfI8dGbRP1D-j_TKFlT6QQk-zb2XsQu_xuB9dLH_jYPrY0dnkjn0m99PJz-ubcrwaofSgl_Dwd-2boJKThgcl6lClqokVD1q3ofauAXEogQsBd4bwNcmIllUhOKjeSSZXiS9ku-u7-JXQKJTgbQoKVqOMiRntYg2rXjTOC6l4Qb6_hsv-GRwwLCoHCKqdzC2XFoNakCuM5GoEulbnB4ClHbG072FZkG-vOFjIcvx14brYL_9ZwbAXVyuuCnI04LL6FFAs2QghC2I2ENuYy-ab7vFXdtJGdaWYNscfMfsTssvxcuC8P3NKthd_l_EMGMuiPc_JeZ63kl4AG5TnhQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+natural+course+of+cystic+pancreatic+neuroendocrine+tumours+in+MEN1&rft.jtitle=Endocrine+oncology&rft.au=van+Vliembergen%2C+Eline+N+M&rft.au=Pieterman%2C+Carolina+R+C&rft.au=van+de+Ven%2C+Annenienke+C&rft.au=Braat%2C+Arthur+J+A+T&rft.date=2025-01-01&rft.issn=2634-4793&rft.eissn=2634-4793&rft.volume=5&rft.issue=1&rft.spage=e240050&rft_id=info:doi/10.1530%2FEO-24-0050&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2634-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2634-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2634-4793&client=summon